» Articles » PMID: 33177308

Prevalence and Prognosis of Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome in Mie Prefecture, Japan - Report From Mie ACS Registry

Overview
Journal Circ J
Date 2020 Nov 12
PMID 33177308
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by elevated low-density lipoprotein cholesterol concentration and premature acute coronary syndrome (ACS). However, hereditary diseases may have regional characteristics, and few data are available regarding the prevalence of FH throughout particular regions in Japan. This study investigated the prevalence and prognosis of FH in patients with ACS in Mie Prefecture, Japan.

Methods and results: This study investigated 738 ACS patients from the Mie ACS Registry in Mie Prefecture, and 706 (95.7%) with sufficient data to diagnose FH were enrolled for analysis. Eighteen patients (2.5%) were diagnosed with FH, which was similar to findings of another multidistrict registry conducted in Japan. Patients with FH were significantly younger and had a higher prevalence of premature onset of ACS than patients with non-FH (P<0.01). Incidence of major adverse cardiac and cerebrovascular events (MACCE) was not statistically different between patients with FH and non-FH in this study population, even in the propensity score-matched analysis.

Conclusions: Prevalence of FH in ACS patients from the Mie Prefecture was similar to that found in another Japanese multidistrict registry. Among ACS patients, short-term incidence of MACCE was not statistically different between patients with FH and non-FH in this study population.

Citing Articles

Prevalence, clinical features and prognosis of familial hypercholesterolemia in Chinese Han patients with acute coronary syndrome after a coronary event: a retrospective observational study.

Kou H, Wang H, Liu P, Wang X, Zhu W, Jiang W BMC Cardiovasc Disord. 2024; 24(1):144.

PMID: 38443803 PMC: 10913252. DOI: 10.1186/s12872-024-03803-4.


Demographic Trends and Changes in the Pre- and In-Hospital Medical Management of Acute Myocardial Infarction During the First 12 Months of the COVID-19 Pandemic in Mie Prefecture - Report From the Mie ACS Registry.

Takasaki A, Kurita T, Yanagisawa M, Ino A, Hiramatsu D, Ikami A Circ Rep. 2022; 4(9):412-421.

PMID: 36120481 PMC: 9437476. DOI: 10.1253/circrep.CR-22-0050.


Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome.

Wang C, Yu P, Hu L, Liang M, Mao Y, Zeng Q Front Cardiovasc Med. 2022; 9:921803.

PMID: 35966514 PMC: 9363594. DOI: 10.3389/fcvm.2022.921803.


Association Between Familial Hypercholesterolemia and Risk of Cardiovascular Events and Death in Different Cohorts: A Meta-Analysis of 1.1 Million Subjects.

Yu Y, Chen L, Zhang H, Fu Z, Liu Q, Zhao H Front Cardiovasc Med. 2022; 9:860196.

PMID: 35800161 PMC: 9253470. DOI: 10.3389/fcvm.2022.860196.


Individualized Treatment for Patients With Familial Hypercholesterolemia.

Tada H, Takamura M, Kawashiri M J Lipid Atheroscler. 2022; 11(1):39-54.

PMID: 35118021 PMC: 8792816. DOI: 10.12997/jla.2022.11.1.39.